Full-Time

Associate Director

Internal Communications

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

501-1,000 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$180k - $225kAnnually

Senior, Expert

San Carlos, CA, USA

Hybrid position requiring in-office presence.

Category
Content Strategy
Creative Writing
Content & Writing
Copywriting
Required Skills
Communications
PowerPoint/Keynote/Slides
Requirements
  • Minimum of [8] years of communications experience with [3] years minimum in a biotech/pharmaceutical company or at a PR/communications agency working with biotech/pharmaceutical clients.
  • Bachelor's degree required, ideally in Communications/Public Relations or related field.
  • Demonstrated ability to design and execute ideas from planning, developing, benchmarking, measuring, etc.
  • Executive presence with the ability to collaborate, lead, facilitate, influence, and organize across groups and at multiple levels of an organization.
  • Excellent organizational savvy with willingness and ability to work independently, think creatively, and shift gears depending on changing priorities and deadlines.
  • Strong creative ability, knowing how to use creative design effectively to enhance employee understanding of business strategies and engagement.
  • Ability to turn complex ideas into stories easily understood by a broad audience.
  • Independent self-starter able to write quickly under deadline with attention to detail and accuracy.
  • Exceptional presentation development skills and strong PowerPoint skills.
  • Strong interpersonal, writing, and verbal communication skills.
  • Ability to manage sensitive and confidential situations.
  • High energy and ability to create a positive working environment for colleagues and clients.
  • Proven ability to establish internal communication and change management best practices.
Responsibilities
  • Lead enhancement and implementation of RevMed’s internal communications strategy and work plan.
  • Support organization-wide initiatives and communications efforts, including: producing internal articles, orchestrating key employee events, and driving digital and multimedia storytelling that helps advance strategic goals.
  • Develop messages, content, and materials to support internal communications strategy, including all internal communication channels (email, intranet, town halls, employee events, digital signage, newsletters, videos, etc).
  • Develop and maintain editorial calendars to drive internal communications in line with company priorities and news flow.
  • Create and strengthen two-way channels for leadership/employee dialogue.
  • Drive communication and change management best practices, including educating the organization around communication norms/best practices.
  • Collaborate with HR to ensure employee communications are well coordinated and aligned with broader internal objectives and messaging.
  • In partnership with Patient Advocacy, use storytelling and events to bring our "tireless commitment to patients" into focus for employees.
  • Partner with IS to refresh and optimize the company’s intranet and other communications platforms.
  • Work closely with the Corporate Affairs team to ensure consistency in internal and external messaging, branding, and priorities for key milestones and data announcements.
  • Measure and report on internal communications activities and impact.
  • Serve as the trusted communications advisor.

Revolution Medicines develops treatments specifically for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main products are RASON Inhibitors, designed to target and inhibit RAS proteins that contribute to cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses solely on RAS-driven cancers, allowing them to tailor their research and development efforts to this specific area. Their goal is to improve cancer treatment outcomes for patients with RAS mutations by providing effective targeted therapies.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-3%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EQRx adds over $1 billion in capital for R&D.
  • FDA fast-tracking supports their RAS-targeted therapy pipeline.
  • Growing interest in targeted cancer therapies boosts investment opportunities.

What critics are saying

  • EQRx acquisition may pose integration challenges and cultural clashes.
  • $600M public stock offering could lead to shareholder dilution.
  • Focus on RAS-addicted cancers limits market scope and increases competition risk.

What makes Revolution Medicines unique

  • Revolution Medicines reconfigures natural substances into best-in-class cancer therapies.
  • Their Tri Complex Inhibitor platform targets RAS proteins driving cancer growth.
  • Exclusive license with University of Illinois enhances their unique synthesis technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity